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2ABSTRACT
Background: Epidemiological studies have documented higher than expected comorbidity (or in
some cases, inverse comorbidity) between schizophrenia and several autoimmune disorders. It
remains unknown whether this comorbidity reflect shared genetic susceptibility loci.
Aims: In the present study, we aimed to investigate whether verified genome wide significant
variants of autoimmune disorders confer risk of schizophrenia which could suggest a common
genetic basis.
Methods: 714 genome wide significant risk variants of 25 autoimmune disorders were extracted
from the NHGRI GWAS catalogue and examined for association to schizophrenia in the Psychiatric
Genomics Consortium schizophrenia GWAS samples (36,989 cases and 113,075 controls).
Results: Two independent loci at 4q24 and 6p21.32–33 originally identified from GWAS of
autoimmune diseases were found genome wide associated with schizophrenia (1.7x10-8≥P≥4.0x10-
21). While these observations confirm the existence of shared genetic susceptibility loci between
schizophrenia and autoimmune diseases, our findings did not show a significant enrichment.
Conclusion: Our findings do not support a genetic overlap in common SNPs between autoimmune
diseases and schizophrenia that in part could explain the observed comorbidity from
epidemiological studies.
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3BACKGROUND
Both schizophrenia and autoimmune diseases are complex disorders caused by multiple genetic and
non-genetic risk factors. Schizophrenia is a severe mental disorder while autoimmune diseases are a
clinical heterogeneous group of diseases with common underlying mechanisms related to an
immune response against self. Recently, genome-wide association studies (GWAS) of large case-
control samples have identified genome-wide significant SNPs implicating several candidate
regions and genes for both autoimmune diseases and schizophrenia (1,2). Here, the most solid
genetic finding for both disorders is that common variants in the major histocompatibility complex
(MHC) on chromosome 6 confer risk of disease but with very different effect sizes (1,3). The MHC
region contains multiple genes and extensive linkage disequilibrium (LD) which have made it
difficult to identify the causal variants but the findings do, however, support the notion that
similarly to autoimmune diseases, inflammatory processes might be involved in the pathogenesis of
schizophrenia (4–8,1). The role of the immune system in the aetiology of schizophrenia is supported
by prenatal infections particular during the second trimester increasing the risk of the disease in the
offspring as well as insult of infectious agents during childhood (9,10).
There is mounting evidence for higher than expected comorbidity (or in some cases, inverse
comorbidity) between schizophrenia and a number of autoimmune disorders both at the individual
and familial level when compared to the general population (11–14) which could reflect a common
genetic basis. Several GWAS have with great success been carried out for both disorders thus; it
seems evident to test for shared genetic susceptibility loci of common SNPs that might contribute to
the observed comorbidity between autoimmune diseases and schizophrenia and point towards
shared molecular pathways and mechanisms.
4AIM
In this study, we examine whether verified genome wide significant variants of autoimmune
disorders confer risk of schizophrenia thereby supporting a common genetic basis.
5MATERIALS AND METHODS
All SNPs showing genome wide association (P≤5.0x10-8) to an autoimmune disease were extracted
from the National Human Genome Research Institute (NHGRI) GWAS catalogue (15)
(http://www.genome.gov/gwastudies/, March, 2015). SNPs from GWAS based on subgroups of
patients, case only studies, response to treatment, haplotype-based associations, or shared risk
alleles between diseases were excluded from the analysis. Thus, a total of 714 unique SNPs
(Supplementary Table 1) of 25 autoimmune disorders from GWAS of European, East Asian, and
North India ancestry were included in the study (Table 1).
We used summary statistics from the Psychiatric Genomics Consortium schizophrenia (PGC-SCZ)
GWAS samples, a large collection of 36,989 cases with schizophrenia and 113,075 controls of
European and East Asian descent (1) (available at http://www.med.unc.edu/pgc/down-loads) to
examine whether these 714 SNPs were genome wide associated with schizophrenia. A more in
depth description of the PGC-SCZ GWAS samples can be obtained from the original publication
(1).
Of the initial 714 SNPs, 706 were present in the PGC-SCZ GWAS samples either by its original
refSNP ID reported in the NHGRI GWAS catalogue (N=629), by its current refSNP ID (N=62,
retrieved from the file RsMergeArch downloaded at http://www.ncbi.nlm.nih.gov) or by a proxy
SNP (N=15, using SNAP (16), 1000 Genomes Pilot 1, CEU reference panel, r2=0.1). The
remaining 8 SNPs were not found in the 1000 Genomes/CEU reference panel.
The 706 aforementioned SNPs present in the PGC-SCZ GWAS samples were spread across nearly
all chromosomes (except chromosome 13 and the Y chromosome) and 90 SNPs were found in the
6MHC region (the extended MHC region was defined as chr6:29,570,005–33,377,699, hg19(17)).
By applying the same LD criteria as in (1), 388 of the 706 analysed SNPs remained (1000 Genomes
Pilot 1, CEU reference panel, r2=0.1 and a 500kb window).
In order to evaluate the robustness of our findings regarding the observed number of shared
susceptibility loci between autoimmune diseases and schizophrenia, we first used the PGC-SCZ
GWAS samples and randomly selected 706 SNPs 1000 times to estimate the expected number of
SNPs that would be associated with schizophrenia by chance.
Second, we used the LD pruned version of the PGC-SCZ GWAS samples where SNPs within
500kb of, and in r2≥0.1 with, another (more significant) SNP were discarded as described in (1). 
From this LD pruned dataset, we randomly extracted 388 SNPs 1000 times where the 388 SNPs
correspond to the number of independent autoimmune loci tested for genome wide association to
schizophrenia (as described above). The observed number of shared susceptibility loci between
autoimmune diseases and schizophrenia found in this study were considered statistical significant if
less than 5% of the number of randomly chosen loci were found with P≤5.0x10-8.
Third, we extracted and evaluated all SNPs within 50kb up- and downstream of the non-MHC gene
BANK1 (chr4:102,711,764–102,995,969, hg19) that had previously been reported in GWAS of
autoimmune diseases (P≤5.0x10-6) (rs4522865 and rs13126505 both associated with systemic lupus
erythematosus (SLE)) from the NHGRI catalogue. Regional association plot was generated using
LocusZoom (18) and all analyses related to the study were carried out using the statistical program
R ver3.1.3 (http://www.r-project.org/).
(TABLE 1 HERE PLEASE)
7RESULTS
A total of 714 risk variants were selected from GWAS of 25 autoimmune disorders (Table 1 and
supplementary Table 1) and evaluated for genome wide association to schizophrenia in the latest
PGC-SCZ GWAS sample in order to identify shared genetic susceptibility loci (see Materials and
Methods for details regarding the SNP selection). Here, 706 SNPs were present in the PGC-SCZ
GWAS sample (corresponding to 388 independent genomic regions) and of these 16 variants were
found genome wide associated with schizophrenia (P≤3.1x10-8, Figure 1-2 and Table 2). Of the 16
identified genome wide associated variants 15 were present in the MHC region on chromosome
6p21.32–33 (strongest P=4.0x10-21) while the last SNP was located in the non-MHC gene BANK1
at chromosome 4q24 (P=1.2x10-8) (Table 2).
Six SNPs originating from celiac disease (rs424232), crohn’s disease (rs13126505), systemic
sclerosis (rs3129763 and rs443198) and rheumatoid arthritis (rs805297 and rs9272219) had the
same direction of effect in the PGC-SCZ GWAS sample while the remaining 10 variants had
opposite effects (N=8) or unavailable at-risk alleles (N=2) despite contact to the corresponding
author of the original GWAS.
To determine whether the 16 observed loci shared between autoimmune diseases and schizophrenia
occurred more often than expected, we first sampled 706 SNPs from the PGC-SCZ GWAS dataset
1000 times (see methods). Here, we did not sample more than 8 loci showing genome wide
association to schizophrenia from the 1000 permutations. However, as 15 of the 16 shared variants
between schizophrenia and autoimmune diseases were situated in the MHC region with strong LD
structures, we in addition found that the two shared independent loci at 6p21.32–33 and 4q24
8showed a considerable trend toward significance since 5.5% of the 388 randomly drawn SNPs from
the LD pruned PGC-SCZ GWAS sample had P≤5x10-8 (Figure 3).
None of the neighbouring SNPs that had previously been associated with an autoimmune disease
(SLE) positioned in the non-MHC gene BANK1 showed additional association to schizophrenia in
the PGC-SCZ GWAS samples (rs4522865, P=5.3x10-2 and rs10516487, P=1.7x10-2, Figure 4 and
Supplementary Table 2).
(TABLE 2 AND FIGURE 1-4 HERE PLEASE)
9CONCLUSSION
Several epidemiological studies have shown that autoimmune diseases occur more frequently in
patients suffering from schizophrenia than in the general population (11–14), however, no studies
have addressed whether this could reflect shared genetic susceptibility loci between the diseases.
This study aimed to make a comprehensive assessment of the genetic overlap of common SNPs
between the two epidemiologically related diseases by investigating whether genome wide
associated variants originally identified from GWAS of autoimmune diseases were genome wide
associated with schizophrenia using the largest GWAS samples of schizophrenia to date (1). Several
aspects of our work merit further discussion.
First, we identified two independent susceptibility loci at 6p21.32–33 and 4q24 shared by specific
autoimmune diseases and schizophrenia (Table 2); however, when compared to randomly selected
SNPs the number of shared loci were only marginally significant (P=0.055) (Figure 3). Thus,
common SNPs captured as significant in current GWAS only contribute with little effect to the
autoimmune comorbidity among patients with schizophrenia that could instead be explained by
non-significant or rare variants interacting with non-genetic factors which have so far not been
addressed in the literature. However, as the GWAS sample size continue to grow it is likely that
more shared susceptibility loci of common SNPs between schizophrenia and autoimmune diseases
will be discovered.
Second, the MHC region on chromosome 6 is a universal genetic susceptibility region for all
autoimmune diseases studied in addition to schizophrenia and the number of shared MHC loci
found in this study, ensured the reliability of our findings. However, the magnitude of effect for
each shared risk variants in the MHC region was markedly different between autoimmune disease
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and schizophrenia (Table 2) which may suggests that specific loci in the MHC region have key
phenotype-determining role for autoimmune diseases when compared to schizophrenia where only
weak effects are present.
Third, the single shared loci outside the MHC region implicating the immune related gene BANK1
could imply an important role for B cell immune response pathways in the pathogenesis of both
autoimmune diseases and schizophrenia. Despite this shared loci being a good candidate pointing
directly towards shared immunological components outside the MHC region, neighbouring SNPs
previous associated with SLE were not genome wide associated with schizophrenia suggesting that
this may not be a true shared locus of association. Similarly, Pouget et al. (19) recently analysed
whether common variation in immune gene outside the MHC region contributed to schizophrenia
and found no enrichment of immune loci which were in contrast to five autoimmune diseases of
known immune origin. Further analysis including the BANK1 locus is necessary in order to clarify
whether this could represent shared pathways involved in both schizophrenia and autoimmune
diseases.
Fourth, several autoimmune disorders have in nation-wide population based register studies been
associated with schizophrenia including the majority of the autoimmune diseases that were found to
share risk variants with schizophrenia in this study (12,13). In addition, we identified shared loci
with opposite directions for schizophrenia contradicting the epidemiological observations (e.g.
autoimmune hepatitis and celiac disease) (12,13) and we did not exclusively find that the at-risk
variants of rheumatoid arthritis are protective of schizophrenia as would be expected based on both
epidemiological and genetic studies (12,13,20,21). These conflicting observations could suggest
that the effect of the underlying causal variant vary among cell types and tissues emphasizing the
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functional importance of the implicated genes and their biological impact and translation into
phenotypes. Discordant associations are a common observation across autoimmune diseases (as
reviewed by Parkes et al. (22)) which highlight the complexity of SNP or haplotype sharing. It has
recently been explained how population-level phenomena (including genetic drift, natural selection,
mutation or migration) are the likely reason behind this complexity of gene effects in different
autoimmune diseases (2) which might also account for the observations in this study.
In summary, by merging GWAS data from multiple autoimmune diseases and schizophrenia we
were not able to show that common SNPs significantly contribute to the observed comorbidity
between the two epidemiologically related diseases.
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LEGENDS OF FIGURES AND TABLES
FIGURE 1. Quantile-quantile plots of the 706 autoimmune SNPs included in the analysis of
the PGC-SCZ GWAS samples.
Fig. 1: A quantile-quantile plot of the 706 SNPs extracted from the NHGRI catalogue of 25
autoimmune diseases. Association testing was performed in the PGC-SCZ GWAS samples of
36,989 schizophrenia cases and 113,075 controls.
FIGURE 2. Risk variants from autoimmune disorders associated with schizophrenia
Fig. 2: Genome wide significant SNPs from autoimmune diseases replicated in the PGC-SCZ
GWAS samples. The negative logarithm of the P-value is plotted against each chromosome. The
vertical red line represents P = 5 x 10-8.
FIGURE 3. Analysis of the number of shared genetic susceptibility loci between autoimmune
diseases and schizophrenia.
Fig. 3: The distribution of P-values (P≤5x10-8) of associated loci for the 388 SNPs drawn randomly
1000 times from the LD pruned version of the PGC-SCZ GWAS samples. The frequency of
randomly drawn loci (SNPs) showing either two or three genome wide associated SNPs per 388
SNPs randomly drawn are 5.1% and 0.4%, respectively being only marginally significant
(P=0.055). The y-axis represents the frequency while the x-axis shows the number of independent
loci with P-values less than 5x10-8 from each extraction of 388 SNPs from the LD pruned version of
the PGC-SCZ GWAS samples.
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FIGURE 4. Regional association plot of the chromosomal region of the non-MHC gene
BANK1.
Fig. 4: A regional plot showing the chromosomal position of the SNP rs13126505 in the gene
BANK1 against –log10(P-value) in the PGC-SCZ GWAS samples. The SNP (rs13126505) that was
found genome wide associated with both an autoimmune disease and schizophrenia are represented
by a purple diamond. The SNPs rs10516487 (PSCZ=1.7x10-2) and rs4522865 (PSCZ=5.3x10-2) that
has previously been associated with and autoimmune disease (red arrows) were not genome wide
associated with schizophrenia. Other SNPs in the region are coloured according to their LD patterns
(generated using LocusZoom).
TABLE 1. The 25 autoimmune diseases included in the study and their respective number of
genome wide associated SNPs
TABLE 2. Association results for verified risk variants for autoimmune diseases in the PGC-
SCZ GWAS samples
SUPPLEMENTARY INFORMATION
Supplementary TABLE 1. The 714 genome wide associated SNPs from autoimmune diseases
included in the study
Supplementary TABLE 2. SNPs previously associated with an autoimmune disease in the
non-MHC gene BANK1
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Table 1. The 25 autoimmune diseases included in the study and their respective number of genome wide associated SNPs
aThe number of SNPs included in the study that are genome wide associated with an autoimmune disease P ≤ 5.0 x 10-8 (extracted from the NHGRI GWAS catalogue).
bThe PubMed ID of the GWAS included in the analysis.
cThe ethnic origin of the subjects from the original GWAS.
Autoimmune Diseases No. of GWA SNPsa References (PMID)b Ethnic originc
Alopecia areata 6 20596022 European
Ankylosing spondylitis 15 22138694;20062062;21743469 European and East Asian
Arthritis (juvenile idiopathic) 1 18576341 European
Autoimmune hepatitis type-1 1 24768677 European
Behcet's disease 13 20622878;23001997;23291587;20622879 European and East Asian
Celiac disease 33 24999842;23936387;20190752;18311140;17558408 European
Crohn's disease 157
22936669;17554261;17554300;22293688;18587394;23266558;17804789;17684544;23850713;
17447842;21102463;22412388;20570966;17435756;23128233 European and East Asian
Dermatomyositis 0 NA NA
Graves' disease 22 21900946;236129;21841780 East Asian
Kawasaki disease 9 22081228;22446962;22446961 European and East Asian
Multiple sclerosis 74
19525955;2245734;21244703;22570697;19525953;18941528;23412934;18997785;22190364;
20598377;20159113;20453840;21833088;17660530 European
Myasthenia gravis 3 23055271 European
Primary biliary cirrhosis 27 21399635;20639880;23000144;19458352 European and East Asian
Primary sclerosing cholangitis 2 21151127 European
Psoriasis 27 19169255;19169254;20953190;18369459;18364390;20953188;20953189 European and East Asian
Psoriatic arthritis 4 22170493;20953186 European
Rheumatoid arthritis 137
21156761;2150507;17804836;17554300;21653640;21844665;20453841;23028356;19503088;
24449572;18794853;17982456;22446963;18668548;24782177;20453842;23918589;21452313;
24390342;24532677 European, East Asian, and North India
Sarcoidosis 2 22837380;229367 European
Sjögren's syndrome 5 24097066 East Asian
Systemic lupus erythematosus 58
19838193;1820409;23053960;23273568;18204447;20169177;19165918;21044949;18204446;
24871463;21408207;22291604 European and East Asian
Systemic sclerosis 14 20383147;21779181;21750679 European
Type 1 diabetes 53
17554300;22293688;17554260;18978792;17632545;18198356;18840781;19430480;19966805;
21980299 European
Ulcerative colitis 91
19122664;20228798;18836448;19915572;20228799;20848476;19915573;21297633;23511034;
24837172;23128233 European, East Asian, and North India
Vitiligo 29 20526339;22951725;21326295;20410501;22561518 European and East Asian
Wegener's granulomatosis 2 23740775 European
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Table 2. Association results for verified risk variants for autoimmune diseases in
schizophrenia
GWAS SNPADa Region AD(s) Risk alleleAD PAD ORAD Mapped gene A1/A2SCZ PSCZ ORSCZ
rs2647044* 6p21.32 T1D A 1.0x10-16 8.3 A/G 4.0x10-21 0.84
rs3131379 6p21.33 SLE A 2.0x10-52 2.4 MSH5 A/G 1.9x10-18 0.85
rs558702* 6p21.33 SLE A 8.0x10-21 2.3 C2;ZBTB12 A/G 3.3x10-18 0.85
rs3130544* 6p21.33 MG A 2.0x10-90 5.6 A/C 3.6x10-18 0.86
rs2596565* 6p21.33 RA Ab 9.0x10-9 1.4 A/G 3.8x10-18 0.85
rs3134792* 6p21.33 PS - 1.0x10-9 - T/G 4.8x10-18 1.17
rs2040406* 6p21.32 MS G 1.0x10-20 2.1 A/G 3.7x10-16 1.13
rs2187668* 6p21.32 AH, SLE ,CD Tb/T/T 2.0x10-78/1.0x10-50/6.0x10-28 2.9/6.2/2.2 HLA-DQA1 T/C 2.6x10-13 0.87
rs1150754 6p21.33 SLE T 6.0x10-29 2.2 TNXB T/C 5.2x10-12 0.90
rs805297* 6p21.33 RA A 3.0x10-10 1.6 BAG6;APOM A/C 1.1x10-10 1.08
rs9272219* 6p21.32 RA Gb 1.0x10-45 1.9 T/G 2.4x10-10 0.92
rs2157337* 6p21.32 RA - 9.0x10-52 - T/C 7.7x10-10 0.92
rs424232* 6p21.32 CD C 5.0x10-21 - T/C 7.9x10-10 0.92
rs443198* 6p21.32 SSc A 9.0x10-21 1.8 NOTCH4 A/G 1.0x10-9 1.08
rs13126505 4q24 CSD A 2.0x10-12 1.2 BANK1 A/G 1.2x10-8 1.14
rs3129763* 6p21.32 SSc Gb 1.0x10-11 1.7 A/G 1.7x10-8 0.93
A1 is reference allele for the odds ratio. “-“ indicate that the information is unavailable. Unadjusted P-values are given.
Abbreviations: OR, odds ratio; P, P-value; AD; autoimmune disease, SCZ; Schizophrenia, SLE; Systemic lupus erythematosus, RA;
Rheumatoid arthritis, AH; Autoimmune hepatitis, SSc; Systemic sclerosis, T1D; Type 1 diabetes, CD; Celiac disease, MG;
Myasthenia gravis, PS; Psoriasis, CSD; Crohn’s disease.
a Genome wide significant SNP for an autoimmune disease extracted from NHGRI GWAS catalogue.
b The risk allele are obtained by personal communication with the corresponding author.
* SNPs found in the Psychiatric Genomics Consortium schizophrenia GWAS samples by a different refSNP ID than reported in the
NHGRI GWAS catalogue.
Supplementary information
Supplementary table 1. The 714 genome wide associated SNPs from autoimmune diseases included in the study
ID SNP ID SNP ID SNP ID SNP ID SNP ID SNP ID SNP ID SNP ID SNP ID SNP ID SNP ID SNP ID SNP ID SNP
1. rs10036748 52. rs11089637 103. rs12191877 154. rs13330176 205. rs1738074 256. rs2150702 307. rs2413583 358. rs3091315 409. rs3814231 460. rs4795067 511. rs624988 562. rs7015630 613. rs773125 664. rs9268645
2. rs1004446 53. rs11117432 104. rs1219414 155. rs13333054 206. rs17391694 257. rs2155219 308. rs2425752 359. rs3091316 410. rs3821236 461. rs479777 512. rs638893 563. rs7020673 614. rs7731626 665. rs9268839
3. rs10045431 54. rs11129295 105. rs12212193 156. rs1335532 207. rs17445836 258. rs2157337 309. rs2451258 360. rs3091338 411. rs3823355 462. rs4802307 513. rs6421571 564. rs702873 615. rs77331626 666. rs9268853
4. rs10065637 55. rs11150589 106. rs12242110 157. rs13361189 208. rs17482078 259. rs2187668 310. rs2456973 361. rs3093023 412. rs3824660 463. rs4809330 514. rs6426833 565. rs703842 616. rs7743761 667. rs9268877
5. rs10168266 56. rs11154801 107. rs12251307 158. rs13385731 209. rs17582416 260. rs2188962 311. rs2469434 362. rs3093024 413. rs3825932 464. rs4810485 515. rs6441286 566. rs706778 617. rs7746082 668. rs9268923
6. rs1016883 57. rs11167764 108. rs12261843 159. rs13428812 210. rs17695092 261. rs2201841 312. rs2474619 363. rs3118470 414. rs3828309 465. rs4813003 516. rs6445975 567. rs706779 618. rs7748270 669. rs9270984
7. rs10175798 58. rs11171739 109. rs12368653 160. rs1372072 211. rs17696736 262. rs2205960 313. rs2476601 364. rs3125734 415. rs3893464 466. rs4819388 517. rs6451493 568. rs7076156 619. rs7752903 670. rs9271100
8. rs10181042 59. rs11175593 110. rs12379034 161. rs1373692 212. rs17716942 263. rs2228145 314. rs2523393 365. rs3129763 416. rs3897478 467. rs4820425 518. rs6457617 569. rs7090512 620. rs7758128 671. rs9271366
9. rs10201872 60. rs11190140 111. rs12413578 162. rs1385374 213. rs17728338 264. rs2230926 315. rs2542151 366. rs3129882 417. rs4077515 468. rs4822024 519. rs6457620 570. rs7097397 621. rs7765379 672. rs9271588
10. rs10210302 61. rs11195128 112. rs12466022 163. rs1393350 214. rs17810546 265. rs2233152 316. rs254560 367. rs3129889 418. rs4085613 469. rs483905 520. rs6478106 571. rs7111341 622. rs7774434 673. rs9272219
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Supplementary information
Supplementary table 2. SNPs previously associated with an autoimmune disease in the non-
MHC gene BANK1
GWAS SNPADa Region Position(hg19) AD(s) Risk alleleAD PAD ORAD Mapped gene A1/A2SCZ PSCZ ORSCZ
rs13126505 4q24 102865304 CSD A 2.0x10-12 1.2 BANK1 A/G 1.2x10-8 1.14
rs10516487 4q24 102751076 SLE G 4.0x10-10 1.4 BANK1 A/G 1.7x10-2 1.03
rs4522865 4q24 102715888 SLE A 5.0x10-6 1.4 BANK1 A/G 5.3x10-2 1.03
A1 is reference allele for the odds ratio. Unadjusted P-values are given. Abbreviations: OR, odds ratio; P, P-value; AD; autoimmune
disease, SCZ; Schizophrenia, SLE; Systemic lupus erythematosus, CSD; Crohn’s disease.
a SNPs associated with an autoimmune disease (P ≤ 5.0x10-6) extracted from NHGRI GWAS catalogue.
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